Retinal vascular occlusions
Acute retinal vascular occlusions are common causes of visual impairment. Although both
retinal artery occlusions and retinal vein occlusions are associated with increased age and …
retinal artery occlusions and retinal vein occlusions are associated with increased age and …
Ten years of anti-vascular endothelial growth factor therapy
N Ferrara, AP Adamis - Nature reviews Drug discovery, 2016 - nature.com
The targeting of vascular endothelial growth factor A (VEGFA), a crucial regulator of both
normal and pathological angiogenesis, has revealed innovative therapeutic approaches in …
normal and pathological angiogenesis, has revealed innovative therapeutic approaches in …
Code-free deep learning for multi-modality medical image classification
A number of large technology companies have created code-free cloud-based platforms that
allow researchers and clinicians without coding experience to create deep learning …
allow researchers and clinicians without coding experience to create deep learning …
Guidelines for the management of retinal vein occlusion by the European Society of Retina Specialists (EURETINA)
U Schmidt-Erfurth, J Garcia-Arumi, BS Gerendas… - …, 2019 - karger.com
The high prevalence of cardiovascular disease particularly in the elderly population is
associated with retinal vascular disease. Retinal vein occlusions represent severe …
associated with retinal vascular disease. Retinal vein occlusions represent severe …
Molecular pathogenesis of retinal and choroidal vascular diseases
PA Campochiaro - Progress in retinal and eye research, 2015 - Elsevier
There are two major types of ocular neovascularization that affect the retina, retinal
neovascularization (NV) and subretinal or choroidal NV. Retinal NV occurs in a group of …
neovascularization (NV) and subretinal or choroidal NV. Retinal NV occurs in a group of …
Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
K Ghasemi Falavarjani, QD Nguyen - Eye, 2013 - nature.com
Intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents is increasingly
used for the treatment of a wide variety of retinal diseases, including age-related macular …
used for the treatment of a wide variety of retinal diseases, including age-related macular …
Anti‐vascular endothelial growth factor for diabetic macular oedema
G Virgili, M Parravano, F Menchini… - Cochrane Database of …, 2014 - cochranelibrary.com
Background Diabetic macular oedema (DMO) is a common complication of diabetic
retinopathy. Although grid or focal laser photocoagulation has been shown to reduce the risk …
retinopathy. Although grid or focal laser photocoagulation has been shown to reduce the risk …
Intravitreal aflibercept for macular edema following branch retinal vein occlusion: 52-week results of the VIBRANT study
Purpose To determine week 52 efficacy and safety outcomes in eyes with macular edema
after branch retinal vein occlusion (BRVO) treated with 2 mg intravitreal aflibercept injection …
after branch retinal vein occlusion (BRVO) treated with 2 mg intravitreal aflibercept injection …
[HTML][HTML] VEGFR1 signaling in retinal angiogenesis and microinflammation
Five vascular endothelial growth factor receptor (VEGFR) ligands (VEGF-A,-B,–C,-D, and
placental growth factor [PlGF]) constitute the VEGF family. VEGF-A binds VEGF receptors 1 …
placental growth factor [PlGF]) constitute the VEGF family. VEGF-A binds VEGF receptors 1 …
Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial
PURPOSE: To assess long-term safety and efficacy of intraocular ranibizumab injections in
patients with macular edema after retinal vein occlusion (RVO). DESIGN: Open-label …
patients with macular edema after retinal vein occlusion (RVO). DESIGN: Open-label …